The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 25 January 2005, www.theannals.com, DOI 10.1345/aph.1E322.
 The Annals of Pharmacotherapy: Vol. 39, No. 3, pp. 523-526. DOI 10.1345/aph.1E322
© 2005 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow For Our Patients
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Backes, J. M
Right arrow Articles by Gibson, C. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Backes, J. M
Right arrow Articles by Gibson, C. A

DRUG INFORMATION ROUNDS

OBJECTIF: Réviser les effets du traitement hypolipémiant sur les lipoprotéines de basse densité petites et denses (LDL-PD).

REVUE DE LITTÉRATURE: Littérature repérée par une recherche sur MEDLINE (1989 à septembre 2004) et la bibliographie des articles sélectionnés; mots-clés: lipoprotéines de basse densité petites et denses, traitement hypolipémiant.

RÉSUMÉ: Les statines, les fibrates, et l'acide nicotinique ont montré des effets favorables sur les LDL-PD, en particulier chez les patients avec des dyslipidémies mixtes ou des hypertriglycéridémies. Ces effets comportent une réduction des LDL-PD et/ou un transfert vers des LDL plus grosses, moins athérogènes.

CONCLUSIONS: Les données suggèrent que les statines, les fibrates, et l'acide nicotinique sont efficaces pour réduire les concentrations de LDL-PD et peut-être pour normaliser les sous-classes de LDL.

www.theannals.com, DOI 10.1345/aph.1E322



This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow For Our Patients
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Backes, J. M
Right arrow Articles by Gibson, C. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Backes, J. M
Right arrow Articles by Gibson, C. A

homecopy help contact us subscription past issues search current issue
Copyright © 2005 by Harvey Whitney Books Company.